Litcius/Paper detail

Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab

Florian Eude, Florian Guisier, Mathieu Salaün, Luc Thiberville, Thibault Pressat-Laffouilhere, Pierre Véra, Pierre Decazes

2022Annals of Nuclear Medicine14 citationsDOI

Topics & Concepts

MedicineLung cancerUnivariate analysisCancerMultivariate analysisInternal medicinePembrolizumabNuclear medicineSurvival analysisReceiver operating characteristicProportional hazards modelPositron emission tomographyOncologyPathologyGastroenterologyImmunotherapyInflammatory Biomarkers in Disease PrognosisRadiomics and Machine Learning in Medical ImagingLung Cancer Diagnosis and Treatment
Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab | Litcius